Metabolic pathways in obesity-related breast cancer

被引:0
|
作者
Kristy A. Brown
机构
[1] Weill Cornell Medicine,Sandra and Edward Meyer Cancer Center and Department of Medicine
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
This Review focuses on the mechanistic evidence for a link between obesity, dysregulated cellular metabolism and breast cancer. Strong evidence now links obesity with the development of 13 different types of cancer, including oestrogen receptor-positive breast cancer in postmenopausal women. A number of local and systemic changes are hypothesized to support this relationship, including increased circulating levels of insulin and glucose as well as adipose tissue-derived oestrogens, adipokines and inflammatory mediators. Metabolic pathways of energy production and utilization are dysregulated in tumour cells and this dysregulation is a newly accepted hallmark of cancer. Dysregulated metabolism is also hypothesized to be a feature of non-neoplastic cells in the tumour microenvironment. Obesity-associated factors regulate metabolic pathways in both breast cancer cells and cells in the breast microenvironment, which provides a molecular link between obesity and breast cancer. Consequently, interventions that target these pathways might provide a benefit in postmenopausal women and individuals with obesity, a population at high risk of breast cancer.
引用
收藏
页码:350 / 363
页数:13
相关论文
共 50 条
  • [31] Symposium 3: Obesity-related cancers Visceral obesity, metabolic syndrome, insulin resistance and cancer
    Doyle, Suzanne L.
    Donohoe, Claire L.
    Lysaght, Joanne
    Reynolds, John V.
    PROCEEDINGS OF THE NUTRITION SOCIETY, 2012, 71 (01) : 181 - 189
  • [32] Metabolic obesity phenotypes and obesity-related cancer risk in the National Health and Nutrition Examination Survey
    Winn, Maci
    Karra, Prasoona
    Freisling, Heinz
    Gunter, Marc J. J.
    Haaland, Benjamin
    Litchman, Michelle L. L.
    Doherty, Jennifer A. A.
    Playdon, Mary C. C.
    Hardikar, Sheetal
    ENDOCRINOLOGY DIABETES & METABOLISM, 2023, 6 (04)
  • [33] Can Bariatric and Metabolic Surgery Prevent Cancer Recurrence in Obesity-Related Neoplasms?
    Chiappetta, Sonja
    Bottino, Vincenzo
    Farina, Amalia
    OBESITY SURGERY, 2022, 32 (10) : 3469 - 3470
  • [34] Metabolic Health Reduces Risk of Obesity-Related Cancer in Framingham Study Adults
    Moore, Lynn L.
    Chadid, Susan
    Singer, Martha R.
    Kreger, Bernard E.
    Denis, Gerald V.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2014, 23 (10) : 2057 - 2065
  • [35] Can Bariatric and Metabolic Surgery Prevent Cancer Recurrence in Obesity-Related Neoplasms?
    Sonja Chiappetta
    Vincenzo Bottino
    Amalia Farina
    Obesity Surgery, 2022, 32 : 3469 - 3470
  • [36] OBESITY-RELATED NEUTROPHILIA IN ENDOMETRIAL CANCER
    Cheung, M.
    O'Brien, O.
    Byrne, D.
    Geoghegan, T.
    LeRoux, C.
    Brennan, D.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A111 - A111
  • [37] Role of hepatic desaturases in obesity-related metabolic disorders
    Bjermo, Helena
    Riserus, Ulf
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2010, 13 (06): : 703 - 708
  • [38] Evaluation of Metabolic Risk Marker in Obesity-related Glomerulopathy
    Chen, Hui-Mei
    Chen, Yan
    Zhang, Yi-De
    Zhang, Pei-Pei
    Chen, Hui-Ping
    Wang, Qing-Wen
    Li, Lei-Shi
    Liu, Zhi-Hong
    JOURNAL OF RENAL NUTRITION, 2011, 21 (04) : 309 - 315
  • [39] Role of the Gut Microbiome in the Pathogenesis of Obesity and Obesity-Related Metabolic Dysfunction
    Bouter, Kristien E.
    van Raalte, Daniel H.
    Groen, Albert K.
    Nieuwdorp, Max
    GASTROENTEROLOGY, 2017, 152 (07) : 1671 - 1678
  • [40] No Role for Mast Cells in Obesity-Related Metabolic Dysregulation
    Chmelar, Jindrich
    Chatzigeorgiou, Antonios
    Chung, Kyoung-Jin
    Prucnal, Marta
    Voehringer, David
    Roers, Axel
    Chavakis, Triantafyllos
    FRONTIERS IN IMMUNOLOGY, 2016, 7